Drugs / Selmevit
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02027337 | Dec 2013 → Mar 2015 | menstrual disorder, polycystic ovary syndrome | Tyumen State Medical Academy | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Selmevit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027337 ↗ |
| Route | Oral | “Two pills of Selmevit in each day during 30 days” NCT02027337 ↗ |